Clinica Baviera, Europe’s only quoted ophthalmology group, increased sales by over 3% but with pre-tax profit and EBITDA both down, its overall performance appears to have been hamstrung by its international operations. We speak to Meritxell Pérez de Castro-Acuña, head of investor relations at Clinica Baviera, about its results.